1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS) / National Institutes of Health (NIH). This R25 program provides support for institutions to develop and disseminate training programs for predoctoral and postdoctoral researchers in clinical and translational science.
Get alerted about grants like this
Get emailed when new opportunities from “National Center for Advancing Translational Sciences (NCATS) / National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
PAR-25-197: Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. Department of Health and Human Services Part 1.
Overview Information Participating Organization(s) National Institutes of Health ( NIH ) Components of Participating Organizations National Center for Advancing Translational Sciences ( NCATS ) Funding Opportunity Title Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) March 31, 2025 - This funding opportunity was updated to align with agency priorities.
Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084 .
August 31, 2022 - Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198 . August 5, 2022 - Implementation Details for the NIH Data Management and Sharing Policy.
See Notice NOT-OD-22-189 . July 22, 2019 - Requirement for ORCID iDs for Individuals Supported by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020. See Notice NOT-OD-19-109 .
Funding Opportunity Number (FON) Companion Funding Opportunity Only one R25 application per UM1 applicant institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.
Assistance Listing Number(s) Funding Opportunity Purpose The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.
To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: This NOFO is part of a required set of companion applications: the Clinical and Translational Science Award (UM1) and companion Institutional Career Development Award (K12). The remaining NOFOs in the suite are optional and include the Ruth L.
Kirschstein National Research Service Award (NRSA) institutional training programs (T32 predoctoral and T32 postdoctoral), the Research Education Grant (R25), and the Specialized Innovation Program (RC2). These optional NOFOs are only available to CTSA Program UM1 applicants and award recipients. Applications to the companion NOFOs cannot be awarded until an award has been issued for the UM1.
(See Section III. Eligibility Information of this NOFO and the respective NOFOs for more information).
Funding Opportunity Announcement Goal(s) The mission of the National Center for Advancing Translational Sciences (NCATS) is to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
Open Date (Earliest Submission Date) Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed All applications are due by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Required Application Instructions It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide , except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts ). Conformance to all requirements (both in the How to Apply - Application Guide and the NOFO) is required and strictly enforced.
Applicants must read and follow all application instructions in the How to Apply - Application Guide as well as any program-specific instructions noted in Section IV . When the program-specific instructions deviate from those in the How to Apply - Application Guide , follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
There are several options available to submit your application through Grants. gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
Use the NIH ASSIST system to prepare, submit and track your application online. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants. gov and eRA Commons to track your application.
Check with your institutional officials regarding availability. Workspace to prepare and submit your application and eRA Commons to track your application. Part 1.
Overview Information Part 2. Full Text of Announcement Section I. Funding Opportunity Description Section II.
Award Information Other Award Budget Information Section III. Eligibility Information Section IV. Application and Submission Information Section V.
Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII.
Other Information Part 2. Full Text of Announcement Section I. Funding Opportunity Description The NIH Research Education Program (R25) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers.
The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. This is a limited competition.
The overarching goal of this R25 program is to provide support to recipients of Clinical and Translational Science Awards (CTSA) for research experiences that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.
To accomplish this over-arching goal, this Notice of Funding Opportunity (NOFO) will support creative educational activities with a primary focus on: Research experiences are expected to be relevant to NCATS mission of studying translation on a system-wide level, agnostic to a specific disease, to better understand the scientific and operational principles underlying each step of the translational process.
The goal is not to focus on specific diseases, but on what is common among them and the translational science process.
Examples of research experiences appropriate for career levels include, but are not limited to: Undergraduates (including those at community colleges): to provide hands-on exposure to research that reinforces their interest in clinical and translational science and/or prepares them for graduate school matriculation and/or careers in clinical and translational science for graduate and medical, dental, nursing and other health professional students.
Graduate Research and Clinical Students, Postdoctoral Fellows and Medical Residents: to extend their skills, experiences, and knowledge base in order to engage in clinical and translational science research activities. Junior Faculty: to enhance their research skills, experiences, and knowledge base relative to clinical and translational science by working with faculty members at a partnering institution.
Proposed research experiences should involve an innovative approach to provide hands-on exposure to clinical and translational science research in a laboratory or a field setting for a full-time (40 hours per week) period of 10 to 15 weeks in order to stimulate the interest and advance the knowledge base of participants to consider further education and training for future careers as clinical and translational science researchers.
The proposed programs should provide research experiences that are not available through formal NIH training mechanisms.
R25 programs that propose at least 10 weeks, but fewer than 15 weeks, of full-time research experiences are allowed to request continued part-time support for the participants to work on their research projects, up to the equivalent of 15 weeks of full-time participation, as long as the entire research experience is completed within a 12-month period.
Successful participants may be appointed for additional periods of short-term research experiences. If awarded, an R25 program is expected to provide training experiences to a cohort of participants in each year of the award, including year one.
Research education programs may complement ongoing research training and education occurring at the applicant institution, but the proposed educational experiences must be distinct from those training and education programs currently receiving Federal support. R25 programs may augment institutional research training programs (e.g., T32, T90) but cannot be used to replace or circumvent Ruth L.
Kirschstein National Research Service Award (NRSA) programs. The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), is transforming the translational science process so that new treatments and cures for disease can be delivered to patients faster.
NCATS strives to develop innovations to reduce, remove or bypass costly and time-consuming bottlenecks in the translational research pipeline in an effort to speed the delivery of new drugs, diagnostics and medical devices to patients. Translation, translational research, and translational science are related but different.
Translation turns observations in the laboratory, clinic, and community into diagnostics, therapeutics, medical procedures, and behavioral changes that improve peoples health. Translational research moves a project to the next step in the translational process. Translational science enables these projects to reach their goals faster and more efficiently.
At NCATS, we define translational science as the field that generates scientific and operational innovations that overcome the long-standing barriers along the translational research pipeline. With its focus on improving the process, translational science ultimately leads to more treatments for all people more quickly. The NCATS Translational Science Principles characterize effective approaches for advancing translational progress.
These principles are described on the NCATS website ( https://ncats. nih. gov/about/about-translational-science/principles ).
These principles are intentionally broad and apply to research anywhere along the translational continuum. While they exemplify translational science approaches, they are not intended to be comprehensive.
The goal of the NCATS Clinical and Translational Science Awards (CTSA) Program is to develop innovative solutions that will improve the efficiency, quality and impact of the process for turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public.
Sustaining a vibrant clinical and translational research enterprise requires a 21 st century workforce that can advance clinical and translational science that will, in turn, increase the efficiency and efficacy of translation with the ultimate goal of getting more treatments to more patients more quickly. Examples of research experiences include: Research experiences centered on the conduct of translational science research.
Participants should be exposed to the spectrum that represents each stage of translational science research that includes the path from the biological basis of health and disease to interventions that improve the health of individuals and the public https://ncats. nih. gov/translation/spectrum .
Providing research experiences within and outside of academia (e.g., industry, regulatory agency, nonprofit patient-advocacy group) beyond the home CTSA hub. Research experiences focused on entrepreneurship and commercialization that broaden the impact of scientific findings beyond the laboratory.
Support research experiences for participants from less research-intensive partner institutions to gain clinical and translational science research experiences. Support faculty from less research-intensive partner institutions to gain research experiences on improving instruction and mentoring capacity in clinical and translational science at their home institutions.
Applications Not Responsive to this NOFO The following types of applications will be deemed nonresponsive and will not be reviewed: Applications that are not submitted concurrently with the required UM1 PAR-21-293 or PAR-24-272 Clinical and Translational Science Award) application, or while the required UM1 application is either in review, under consideration for funding, or has been awarded.
Applications that do not meet the criteria noted under the eligibility criteria (see Section III). Applications that do not submit all of the required attachments. Application information, including Frequently Asked Questions and Technical Assistance Webinars, are found on https://ncats.
nih. gov/research/research-activities/ctsa/applicant-information . See Section VIII.
Other Information for award authorities and regulations. Section II. Award Information Grant: A financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.
Application Types Allowed Resubmission - Resubmission Applications for PAR-21-339 and this NOFO The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO. Not Allowed: Only accepting applications that do not propose clinical trial(s).
Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. The maximum budget is $100,000 direct costs/year.
The budget request for a given application needs to be adequately justified and reflect the actual needs of the proposed project. Yearly fluctuations in the project workload should be reflected in the requested budget. Applicants are expected to provide training experience to a cohort of participants in each year of the award.
The scope of the proposed project should determine the project period. The maximum project period is 5 years. Other Award Budget Information Individuals designing, directing, and implementing the research education program may request salary and fringe benefits appropriate for the person months devoted to the program.
Salaries requested may not exceed the levels commensurate with the institution's policy for similar positions and may not exceed the congressionally mandated cap. (If mentoring interactions and other activities with participants are considered a regular part of an individual's academic duties, then any costs associated with the mentoring and other interactions with participants are not allowable costs from grant funds).
Total allowable personnel (including consultants) cost should be proportional to the number of participants in the program. For each participant, up to $3,500 (Direct Cost) is allowed for personnel (including consultant) costs per year. All personnel and consultant costs must be itemized and adequately justified.
Participants are those individuals who receive the hands-on research experiences offered through the R25 program. Participant costs must be itemized in the Participant/Trainee Support Costs section of the requested budget and sufficient justification must be provided. Participant costs are restricted and cannot be re-budgeted.
Allowable participant costs include: Round-trip travel to and from the R25 research experience site for non-local participants.
Up to $1,000 per participant is allowed for research education-related expenses that occur during the period of research experience participation, such as lab supplies, poster production costs, books, non-local travel to a conference to present interim findings from the research project, etc. Salary and fringe benefits.
The salary and fringe benefits must reflect an employee-employer relationship between the participant and the institution and are to be consistent with the institutional salary policies for employees in similar positions. Salary plus fringe benefits can be included only when such benefits are provided to other employees in similar positions. A housing allowance can be requested by the program each year.
The average cost for the housing allowance may not exceed $1,000 per participant.
Unallowable participant costs include: Daily meals and local transportation costs based on institutional policy Gifts, such as hats, t-shirts, key rings, tote bags, refreshments, etc. Social functions that include food and beverages without an associated R25 program educational activity Incentive payments to participants for the completion of R25-required activities, surveys, or other program components Dues to professional organizations, outside of registration to attend and present research at a professional meeting Individuals supported by NIH training and career development mechanisms (K, T, or F awards) may receive, and indeed are encouraged to participate in educational experiences supported by an R25 program but may not receive salary or stipend supplementation from an R25 program.
The appointment of participants to this R25 cannot overlap with an appointment on another NRSA/PHS supported program including but not limited to NIH Career Development Awards (K), NRSA Training Grants (T32, T35) or NRSA Fellowship Grants (F30, F31, F32, F99).
Reasonable Accommodations for Individuals with Disabilities: As part of this award, funds may be requested to make changes or adjustments in the research setting that will make it possible for an otherwise qualified individual with a disability to participate in the program.
The accommodation(s) requested under this program must be directly related to the performance of the proposed role on the research project and must be appropriate to the disabilities of the individual. Some types of accommodations that might be provided include specialized equipment, assistive devices and personnel such as readers, interpreters, or assistants.
In all cases, the total funds for accommodation(s) must be reasonable and justified and documentation of the disability should be included when a request for additional funds is made post-award. These additional funds are in excess of the expenses allowed under "Participation Costs" above.
Because the R25 program is not intended as a substitute for an NRSA institutional training program (e.g., T32), costs to support full-time participants (supported for 40 hours/week for a continuous, 12-month period) are not allowable. Other Program-Related Expenses Consultant costs, equipment, supplies, travel for key persons, and other program-related expenses may be included in the proposed budget.
These expenses must be justified as specifically required by the proposed program and must not duplicate items generally available at the applicant institution. Note that consultants may include individuals serving in a variety of roles, such as faculty, lecturers, advisors, etc., and that consultant costs are capped, depending on the personnel costs and the number of participants in the research experiences program.
See Personnel Costs section above for details. Voluntary committed cost share will not be accepted and will not be considered in the review score for participant salaries and fringe benefits. Any applicant identifying voluntary committed cost share in the budget sections of the application will be bound to the cost share commitment for the entire approved project period.
All costs included in the budget section of the application must be allowable costs per the NOFO. Unallowable costs will be removed prior to award. Personnel effort requested without salary support will be considered voluntary committed cost share, and the applicant institution will be bound to the relevant salary, fringe and associated Facilities & Administrative (F&A) costs for the entire approved project period.
Applicants may describe other institutional support available to enhance the training experience in the Facilities & Other Resources attachment and/or the Institutional Environment and Commitment to Training and section of the application.
Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are reimbursed at 8% of modified total direct costs (exclusive of tuition and fees, expenditures for equipment and consortium costs in excess of $25,000), rather than on the basis of a negotiated rate agreement. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO. Section III.
Eligibility Information All applicant organizations and/or active award recipients for PAR-21-293 or PAR-24-272 Clinical and Translational Science Award (UM1 Clinical Trial Optional) are eligible to apply under this NOFO. Only the primary UM1 CTSA hub organization is eligible to apply. Partner/Partnering and/or Collaborator/Collaborating institutions are not eligible.
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Program (R25 - Clinical Trial Not Allowed) companion optional applications may be submitted in accordance with the applicable NOFO application submission dates under the following scenarios: concurrently with the UM1 while the UM1 application is under review consideration while the UM1 is under consideration for funding after the UM1 application is funded While optional companion applications may be submitted concurrently with the UM1 application or at any time the submitted UM1 new or resubmission application remains active, optional companion applications will only be awarded if the UM1 is awarded.
The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program includes the provision of adequate staff, facilities, and educational resources that can contribute to the planned program. Institutions with existing Ruth L.
Kirschstein National Research Service Award (NRSA) institutional training grants (e.g., T32) or other Federally funded training programs may apply for a research education grant provided that the proposed educational experiences are distinct from those training programs receiving federal support.
In many cases, it is anticipated that the proposed research education program will complement ongoing research training occurring at the applicant institution. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement , are allowed.
Applicant organizations must complete and maintain the following registrations as described in the How to Apply - Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible.
Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference NIH Grants Policy Statement Section 2. 3. 9.
2 Electronically Submitted Applications for additional information. System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually . The renewal process may require as much time as the initial registration.
SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. Unique Entity Identifier (UEI) – A UEI is issued as part of the SAM.
gov registration process. The same UEI must be used for all registrations, as well as on the grant application. eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.
gov registration; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application. Grants.
gov – Applicants must have an active SAM registration in order to complete the Grants. gov registration. Program Directors/Principal Investigators (PD(s)/PI(s)) All PD(s)/PI(s) must have an eRA Commons account.
PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Eligible Individuals (Program Director/Principal Investigator) Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply - Application Guide .
The PD/PI should be an established investigator (successfully competed for an R01 or R01-equivalent grant) in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI will be expected to monitor and assess the program and submit all documents and reports as required.
The UM1 PD(s)/PI(s) may not be a PD(s)/PI(s) on the R25 application or award in order to ensure the PD(s)/PI(s) have adequate time to devote to the respective programs. This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1. 2 Definition of Terms .
3. Additional Information on Eligibility Applicant organizations may NOT submit more than one application. NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.
3. 7. 4 Submission of Resubmission Application .
This means that the NIH will not accept: A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application. A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
An application that has substantial overlap with another application pending appeal of initial peer review. (see NIH Grants Policy Statement 2. 3.
9. 4 Similar, Essentially Identical, or Identical Applications ) Only one R25 application per institution (normally identified by having a unique UEI number or NIH IPF number) is allowed.
Adhering to the submission eligibility below, a set must contain 1 application to the UM1 NOFO and 1 application to the K12 NOFO; it may also contain 1 application to the T32 predoc NOFO, 1 application to T32 postdoc NOFO, 1 application to this R25 NOFO, and/or up to 2 applications for the RC2 NOFO. Mentors should have research expertise and experience relevant to the proposed program.
Mentors must be committed to continue their involvement throughout the total period of the mentees participation in this award. Participants in R25 programs supported through this NOFO may include undergraduates, graduate research and clinical students (i.e., medical students, dental students, nursing students), postdoctoral fellows, medical residents, and junior faculty.
Unless strongly justified on the basis of exceptional relevance to NIH, research education programs should be used primarily for the education of U.S. citizens and permanent residents. Section IV. Application and Submission Information 1.
Requesting an Application Package The application forms package specific to this opportunity must be accessed through ASSIST, Grants. gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.
gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution. 2.
Content and Form of Application Submission It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide , except where instructed in this Notice of Funding Opportunity to do otherwise. Conformance to the requirements in the How to Apply - Application Guide is required and strictly enforced.
Applications that are out of compliance with these instructions will not be reviewed. All page limitations described in the How to Apply - Application Guide and the Table of Page Limits must be followed. Instructions for Application Submission The following section supplements the instructions found in the How to Apply - Application Guide and should be used for preparing an application to this NOFO.
Follow all instructions provided in the How to Apply - Application Guide , with the following additional instructions: Descriptive Title of Applicants Project: Use the format CTSA Research Education R25 at Name of Institution Cover Letter Attachment: The Cover Letter is one pdf file only.
Applications that are part of a collaborative set must include the following information: a listing of all the applications that are a part of the set of collaborative applications being submitted, including for each: 1) the PD/PI(s) name(s), 2) the NOFO number, 3) the Title of the application, and 4) the Applicant Institution. Each application that is part of the collaborative set should submit an identical listing.
SF424(R&R) Project/Performance Site Locations Follow all instructions provided in the How to Apply - Application Guide . SF424(R&R) Other Project Information Component Follow all instructions provided in the How to Apply - Application Guide with the following additional modifications: Facilities & Other Resources.
Describe the educational environment, including the facilities, laboratories, participating departments, computer services, and any other resources to be used in the development and implementation of the proposed program. List all thematically related sources of support for research training and education following the format for Current and Pending Support.
Appropriate institutional commitment should include the provision of adequate staff, facilities, and educational resources that can contribute to the planned research education program. The applicant must ensure the peer reviewed sections (budget section) of the application focus on the participants to be supported by direct NIH funding via this funding opportunity.
Descriptions of other institutional research education/training programs should be included in the Facilities & Other Resources attachment and/or the Institutional Environment and Commitment to Training section of the application. Coordination and Integration Plan (required, 3-page maximum) . Provide a specific plan describing the partnership between the UM1 and any optional companion application(s).
Describe the overarching goals of each companion application and the coordination, integration, synergy, and mutual reinforcement of resources between them. Include a description of the roles of any shared partners and/or collaborators. Include a description of any proposed team-based or near-peer mentoring aspects, if applicable.
Describe the integration of these activities with the UM1, K12, and this research education program, as well as any other optional companion application(s) as well as with partners and collaborators. Please name the file Coordination_Interaction_Plan. pdf.
If this attachment is not included, the application will be considered incomplete and will not be reviewed. Advisory Committee Plan (optional, 1-page maximum). An Advisory Committee is not a required component of a Research Education program.
However, if an Advisory Committee is intended, provide a plan for the appointment of an Advisory Committee to monitor progress of the research education program. The composition, roles, responsibilities, and desired expertise of committee members, frequency of committee meetings, and other relevant information should be included. Describe how the Advisory Committee will evaluate the overall effectiveness of the program.
Proposed Advisory Committee members should be named in the application if they have been invited to participate at the time the application is submitted. If an Advisory Committee is included, please name your file Advisory_Committee. pdf.
The filename provided for each Other Attachment will be the name used for the bookmark in the electronic application in eRA Commons. SF424(R&R) Senior/Key Person Profile Expanded Follow all instructions provided in the How to Apply - Application Guide .
Follow all instructions provided in the How to Apply - Application Guide with the following additional modifications: Include all personnel other than the PD(s)/PI(s) in the Other Personnel section, including clerical and administrative staff. Use the section on Participant/Trainee Support Costs to include all allowable categories of funds requested to support participants in the program.
Within the budget section, include only line items for participants directly supported by NIH funding via this NOFO. PHS 398 Cover Page Supplement Follow all instructions provided in the How to Apply - Application Guide . All instructions in the How to Apply - Application Guide must be followed, with
According to the current listing, eligibility includes: Eligibility is limited to institutions that have successfully competed for an award under the CTSA UM1 Notice of Funding Opportunity or subsequent iterations. Confirm the full requirements in the official notice before applying.
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) is funded by National Center for Advancing Translational Sciences (NCATS) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed) is sponsored by National Center for Advancing Translational Sciences (NCATS) / National Institutes of Health (NIH). This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) Phase I, Phase II, and Fast-Track grant applications.
Translational Centers for Microphysiological Systems (TraCe MPS) is sponsored by National Center for Advancing Translational Sciences (NCATS) / National Institutes of Health (NIH). NCATS has established new centers to strengthen the use of organ-on-a-chip, or tissue chip, technology to develop drugs and potentially reduce the need for animals in research.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read article